In this article published by DIEurope, the University Hospital Erlangen introduces nu:view breast CT, which is in clinical use since 2019.
Dr. Matthias Wetzl, Dr. Sabine Ohlmeyer and Dr. Evelyn Wenkel describe recent clinical findings and give a profound insight into
➔ the photon-counting technology and the resulting advantages for image quality.
➔ and the possible indications for breast CT like problem-solving, preoperative staging and screening.

“Breast CT is so far the only 3D breast imaging method that has been shown to reliably detect micro­calcifications and mass lesions with­out any risk of obscuring lesions because of superimposed tissue.”